Promega France
keyboard_backspaceBack to Home
Contact
24 Chemin des Verrières
69260 Charbonnières-les-Bains
France
Strategic Account Manager
About us
Promega, an independent and innovative life sciences company, stands out for its R&D-focused approach, with over 500 active patents.
Founded over 45 years ago, Promega has established itself as a key player in biotechnology, generating Bioluminescence technologies particularly used in Drug Discovery from the exploratory phase through to clinical batch release, as well as in clinical and diagnostic research.
The French branch, located in Charbonnières-Les-Bains near Lyon, plays a crucial role in innovation and training, housing an application development laboratory unique in Europe.
Promega also stands out for its environmental approach. With ambitious targets for 2030, Promega is demonstrating its commitment to a more sustainable future. These efforts are reinforced by eco-responsible facilities and environmental-friendly products.
This combination of scientific innovation, sustained growth and environmental commitment makes Promega an ideal partner for the scientific community, inviting discovery and collaboration in a spirit of shared progress and global responsibility.
Business offer
As a world leader in the development of innovative technologies for the life sciences for over 40 years, our growth is based on our in-house research activities. Our U.S. R&D center is home to over 200 researchers who have generated more than 500 active patents in molecular and cellular biology. Our technologies are used particularly in drug discovery, from the exploratory to the clinical phase, as well as in production for quality control and batch release.
Our solutions are used in R&D, routine analysis, quality control and biomanufacturing in many fields: academic and pharmaceutical research, molecular diagnostics, genetic identity and applied analysis.
Our mastery of the complete chain, from design, development and manufacturing (ISO and cGMP) to distribution, enables us to offer you high value-added instruments and reagents, as well as customized solutions tailored to your specific business needs. We participate with many of the world's leading manufacturers in the development of diagnostic kits (OEM), and have the customization capabilities to influence volume, packaging, formulation, etc...
With our cell-based assay development and qualification services for drug discovery, we can help you accelerate the discovery and development of your (bio)drugs and vaccines. These comprehensive services include development of new cell-based assays, modification of existing assays, optimization and qualification, (bio)drug profiling on our existing assays, and manufacturing of functional tools.
Activities
- Service
- Technology Supplier
- Oncology
- Infectiology
- Immunology
- Inflammation
- Target selection & validation
- Expression and pathway analysis of target
- quantification of target
- Assay development in in-vitro & in-vivo models
- Research exploratory companion biomarkers
- Hit discovery
- Screening & Identification
- Therapeutic libraries
- In-vivo models
- In-vitro & ex-vivo models
- Indication searching
- Immunotherapy lead generation
- Binding & Affinity
- Potency & Specificity
- Functional effects
- ADCC, ADCP & CDC
- Antigen density target
- Internalization
- Pharmacology & Biological activity
- PK/PD bioavailability
- Mode of Action
- Therapeutic efficacy
- Safety
- Immunogenicity
- Immunotoxicology
- Specificity
- Manufacturability
- Production quality
- Cell activation
- Cell-based activation (APCs, AAPCs)
- Gene modification / Transduction
- CRISPR/Cas9
- Immunotherapy lead optimization
- Proof of concept
- in-vitro & ex-vivo models
- Preclinical biomarkers
- Mechanism/Function
- Mechanism of action
- Drug-Target interaction
- Level of response duration
- Specificity
- Research exploratory Companion biomarkers
- Animal biomarkers
- Human biomarkers
- Predictive biomarkers
- Treatment efficacy
- CMC
- Master Cell Bank
- Cell Line development
- Clone selection
- Characterization
- Quality assurance, quality control & analytical process
- Bioproduction analytical test
- Characterization
- Batch release test
- Chemical, physical, biological test
- Clinical biomarkers
- Predictive biomarkers
- Disease progression monitoring
- Cell modification
- Cell Activation
- Target Identification
- Assay development in in-vitro & in-vivo models
- Antigen identification, selection, optimization, and validation
- Assay development with in-vitro & in-vivo models
- Pathogen-host knowledge
- Pathogen genetics and mechanism of action
- Host interaction (infection mechanisms)
- In-vitro and in-vivo models
- Antigen-protective immune-response profile
- Humoral response characterization:
- Antibody dosage
- Functional antibody assays (neutralization, CDC, ADCC)
- Cell mediated immunity response
- T cell assays
- Vaccine: antigen format platforms
- mRNA vaccine
- Challenge test – Gold Standard
- Induced immune response characterization
- In-vitro models
- CMC
- Gene modification / Transduction
- Molecular biology
- Expression systems
